G
Guizhou Bailing Group Pharmaceutical Co Ltd
SZSE:002424
Guizhou Bailing Group Pharmaceutical Co Ltd
SZSE:002424
Price:
4.87
CNY
4.96%
Market Closed
Market Cap:
¥6.8B
Relative Value
The Relative Value of one Guizhou Bailing Group Pharmaceutical Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 4.87 CNY, Guizhou Bailing Group Pharmaceutical Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Guizhou Bailing Group Pharmaceutical Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Guizhou Bailing Group Pharmaceutical Co Ltd Competitors
Guizhou Bailing Group Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
G
|
Guizhou Bailing Group Pharmaceutical Co Ltd
SZSE:002424
|
6.8B CNY | 2.2 | 3 065.5 | 79.9 | 79.9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
966.3B USD | 14.8 | 46.8 | 31.6 | 33.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
586.6B USD | 6.2 | 21.9 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
291.9B CHF | 4.8 | 31.1 | 13.1 | 15.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
248.6B CHF | 5.7 | 23 | 14.2 | 18.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP | 5.5 | 31.4 | 17.4 | 24.5 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
298.1B USD | 4.6 | 16.3 | 10.2 | 11.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.7B USD | 2.5 | 19.9 | 7.4 | 9.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123B USD | 2.6 | 17.4 | 7.3 | 9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
